In essence, a form of insurance against accidental patent infringement.
Why do you believe accidental patent infringement is a concern for a sizeable number of people producing vaccines?
Option #4: An across the board increase in patent maintenance fees, possibly linked to expected income from a patent.
That seems about “how can we make Eroom’s law keep going” instead of doing anything helpful for biotech (other area’s have different considerations regarding patents).
Actually for the mRNA vaccines accidental patent infringement seems highly likely, since the underlying platform is well understood, much of the research originated in universities with direct government funding, and the genetic code for viruses is routinely released into the public domain.
Why do you believe accidental patent infringement is a concern for a sizeable number of people producing vaccines?
That seems about “how can we make Eroom’s law keep going” instead of doing anything helpful for biotech (other area’s have different considerations regarding patents).
Actually for the mRNA vaccines accidental patent infringement seems highly likely, since the underlying platform is well understood, much of the research originated in universities with direct government funding, and the genetic code for viruses is routinely released into the public domain.
I haven’t looked up “Eroom’s law” yet.